Search Results (129)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Catenacci, Daniel | Person |
Why?
|
Gastroesophageal cancer: focus on epidemiology, classification, and staging. | Academic Article |
Why?
|
Quality of Life, Symptoms, and Self-Management Strategies After Gastroesophageal Cancer Surgery. | Academic Article |
Why?
|
Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design. | Academic Article |
Why?
|
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care. | Academic Article |
Why?
|
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. | Academic Article |
Why?
|
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. | Academic Article |
Why?
|
Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers. | Academic Article |
Why?
|
Gastroesophageal reflux disease: From heartburn to cancer. | Academic Article |
Why?
|
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. | Academic Article |
Why?
|
For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes? | Academic Article |
Why?
|
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction. | Academic Article |
Why?
|
Antireflux surgery for dysplastic Barrett. | Academic Article |
Why?
|
Role of minimally invasive surgery in the modern treatment of Barrett's esophagus. | Academic Article |
Why?
|
Eng, Oliver | Person |
Why?
|